JP Morgan Private Wealth Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-17,670	Closed	-$198K	–	1349
2017 Q3	$198K	Buy	17,670 +227	+1%	+$2.5K	﹤0.01%	1160
2017 Q2	$192K	Hold	17,443	–	–	﹤0.01%	1155
2017 Q1	$171K	Hold	17,443	–	–	﹤0.01%	1264
2016 Q4	$188K	Buy	+17,443	New	+$174K	﹤0.01%	1174

JP Morgan Private Wealth Advisors's SCLN Position: Q4 2017 in Review

JP Morgan Private Wealth Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 17,670 shares — an estimated $198K sold.

JP Morgan Private Wealth Advisors first reported a position in SCLN in Q4 2016 and held it in 4 quarters. The position peaked at $198K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

JP Morgan Private Wealth Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 17,670 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $198K.
JP Morgan Private Wealth Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q4 2016 and held it in 4 quarters.
JP Morgan Private Wealth Advisors's Sciclone Pharmaceuticals Inc position peaked at $198K in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.